^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

RNA synthesis inhibitor

3d
A Study on the Application of Xinran Meiyu in Wound Healing and Complications Following Hair Transplantation (ChiCTR2500113315)
P4, N=116, Not yet recruiting, Southern Medical University Southern Hospital; Southern Medical University Southern Hospital
New P4 trial
8d
A scientometric and comparative study of rhabdomyosarcoma research by pediatricians and stomatologists. (PubMed, J Dent Sci)
Cancer chemotherapy mainly vincristine, dactinomycin, and cyclophosphamide, surgery, radiotherapy, and brachytherapy were the common keywords of treatment. The more common keywords such as age, facial neoplasms, mouth neoplasms, orbital neoplasms, gingiva, mandible, DNA-binding proteins, gene silencing, and Rh30 cell line were reported by stomatologists. This study is the first comprehensive report of the scientometric characteristics of RMS publications by pediatricians and stomatologists, highlighting the need for increased awareness among clinicians to avoid diagnostic delays and ensure timely treatment.
Journal
|
FOXO1 (Forkhead box O1) • PAX3 (Paired Box 3)
|
cyclophosphamide • vincristine • dactinomycin
11d
ABLE: Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries (clinicaltrials.gov)
P3, N=1134, Recruiting, NICHD Global Network for Women's and Children's Health | Not yet recruiting --> Recruiting
Enrollment open
15d
NSUN2 restrains gastric cancer cell apoptosis and ferroptosis by promoting the m5C modification of EPYC. (PubMed, Hereditas)
NSUN2-mediated m5C modification of EPYC contributed to GC cell growth and metastasis, which provided a novel regulatory axis for understanding the pathogenesis of GC.
Journal
|
NOP2 (NOP2 Nucleolar Protein) • NSUN2 (NOP2/Sun RNA Methyltransferase 2)
|
dactinomycin
18d
Rutin alleviates pirarubicin-induced cardiotoxicity and enhances chemosensitivity in breast cancer. (PubMed, Phytomedicine)
Rutin mitigates THP-induced cardiotoxicity and enhances chemotherapeutic efficacy via the novel miR-129-1-3p/GRIN2D pathway. Our data show miR-129-1-3p to be an essential mediator, and suggest that the rutin-miR-129-1-3p-GRIN2D axis is a favorable target for improving the safety and effectiveness of breast cancer chemotherapy.
Journal
|
MIR129 (MicroRNA 129) • MIR129-1 (MicroRNA 129-1) • GRIN2D (Glutamate Ionotropic Receptor NMDA Type Subunit 2D)
|
Pinorubin (pirarubicin)
19d
Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients (clinicaltrials.gov)
P=N/A, N=250, Recruiting, University of Minnesota | Trial primary completion date: Dec 2025 --> Dec 2026
Trial primary completion date
22d
SHIELD: Staph Intervention for Effective Local Defense (clinicaltrials.gov)
P4, N=78, Completed, Johns Hopkins Bloomberg School of Public Health | Active, not recruiting --> Completed
Trial completion
22d
Combination treatment of cordycepin and radiation induces apoptosis accompanied by protective autophagy in TM3 mouse Leydig progenitor cells. (PubMed, J Food Drug Anal)
Although apoptosis is eventually induced in TM3 cells, protective autophagy is also activated to mitigate the cytotoxic impact of the combination treatment. This finding may provide a reference for the development of safe therapeutic regimen for Leydig cell tumors.
Preclinical • Journal
|
ATG5 (Autophagy Related 5) • ATG12 (Autophagy Related 12) • BECN1 (Beclin 1)
|
cordycepin (OVI-123)
22d
Cordycepin in cancer therapy: A bibliometric analysis and review of mechanisms. (PubMed, J Food Drug Anal)
Future research should prioritize pharmacokinetic characterization, investigation of combinatorial therapeutic strategies, and pathways toward clinical translation. Intracellular exposure appears to be shaped by two complementary axes: interference with 3'end polyadenylation and ENT1/ENT2-mediated uptake with ADA-catalyzed deamination.
Review • Journal
|
SLC29A1 (Solute Carrier Family 29 Member 1) • CDKN1A (Cyclin-dependent kinase inhibitor 1A)
|
cordycepin (OVI-123)
24d
Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors (clinicaltrials.gov)
P2, N=127, Recruiting, Second Affiliated Hospital of Soochow University | Not yet recruiting --> Recruiting
Enrollment open
|
CD8 (cluster of differentiation 8)
|
cordycepin (OVI-123)
25d
Cordycepin suppresses the progression of multiple myeloma by inducing ferroptosis through upregulating CLEC2. (PubMed, Cytotechnology)
Collectively, COR inhibited MM progression by inducing ferroptosis through upregulating CLEC2. The online version contains supplementary material available at 10.1007/s10616-025-00886-5.
Journal
|
HIF1A (Hypoxia inducible factor 1, alpha subunit) • GPX4 (Glutathione Peroxidase 4) • ACSL4 (Acyl-CoA Synthetase Long Chain Family Member 4) • SLC7A11 (Solute Carrier Family 7 Member 11)
|
cordycepin (OVI-123)
25d
Targeting the METTL3/PCNA axis with STM2457 overcomes cisplatin resistance in osteosarcoma. (PubMed, Transl Cancer Res)
Mechanistic investigations included quantification of global m6A levels, analysis of PCNA messenger RNA (mRNA) stability via actinomycin D assay, and western blot for protein expression. Our findings demonstrate that STM2457 overcomes cisplatin resistance in OS by targeting the METTL3-m6A-PCNA axis, thereby disrupting a key DNA repair and cell survival pathway. Pharmacological inhibition of METTL3 represents a novel and promising epigenetic strategy for resensitizing chemoresistant OS, supporting its potential for future clinical development.
Journal
|
CASP3 (Caspase 3) • VIM (Vimentin) • PCNA (Proliferating cell nuclear antigen) • METTL3 (Methyltransferase Like 3)
|
cisplatin • dactinomycin